Pharma

Pharma cos, doctors embrace digital transformation to reconnect with each other virtually during pandemic

Pharma cos, doctors embrace digital transformation to reconnect with each other virtually during pandemic

Oct 15, 2021

The doctor’s practice around diagnosing patients and prescribing pharmaceutical brands has also undergone a sea change because of the implementation of telemedicine guidelines.

Improving accessibility to quality medicines for patients through new public procurement order

Improving accessibility to quality medicines for patients through new public procurement order

Oct 12, 2021

The NPPO should aim to promote availability and accessibility to quality medicines.

IPC kickstarts skill development programme on Pharmacovigilance to address adverse events related to drugs, medical devices

IPC kickstarts skill development programme on Pharmacovigilance to address adverse events related to drugs, medical devices

Oct 11, 2021

The skill development programme is a part of government’s ambitious Pradhan Mantri Kaushal Vikas Yojana to produce and nurture qualified pharmacovigilance personnel for effective PV.

Piramal board approves demerger of its pharmaceuticals business from Piramal Enterprises

Piramal board approves demerger of its pharmaceuticals business from Piramal Enterprises

Oct 08, 2021

Piramal Enterprises said its board has approved a composite scheme of arrangement providing for the demerger of its pharmaceuticals business and simplification of the corporate structure to create two listed entities in financial services and pharmaceuticals.

Experts recommend diagnostic, therapeutic interventions for malaria control and elimination in India

Experts recommend diagnostic, therapeutic interventions for malaria control and elimination in India

Oct 07, 2021

To combat devastating effects of Malaria, the NMCP was launched in 1953 built around three key activities – insecticidal residual spray (IRS) with DDT; monitoring and surveillance of cases; and treatment of patients.

Covid-19 thrusting the pharma industry to expand

Covid-19 thrusting the pharma industry to expand

Oct 07, 2021

Prime Minister Narendra Modi said India can help in bringing the world out of the coronavirus crisis with mass vaccine distribution once all trials are completed successfully.

Avoiding pitfalls in life science transactions

Avoiding pitfalls in life science transactions

Oct 07, 2021

Collaborative partnerships are of increasing importance for successful innovation in the life science industry.

More large pharma companies in India are looking to outsource product development and manufacturing to CDMOs: Hitesh Windlass, Windlas Biotech

More large pharma companies in India are looking to outsource product development and manufacturing to CDMOs: Hitesh Windlass, Windlas Biotech

Oct 06, 2021

The outsourcing market size for pharmaceutical manufacturing and development in India roughly stands at 20,000 crores and is expected to grow about 40,000 crores in next five years.

How the power crisis in China will impact Indian pharma

How the power crisis in China will impact Indian pharma

Oct 06, 2021

This cut in power supply has now meant that the industries operating out of such provinces will have limited ability to produce goods and operate on a more rationed basis.

Eli Lilly and Cipla enter into strategic partnership in India to enhance access to Lilly key diabetes products

Eli Lilly and Cipla enter into strategic partnership in India to enhance access to Lilly key diabetes products

Oct 04, 2021

Cipla will leverage its capabilities and robust distribution strengths to engage healthcare professionals and expand access to these treatments for patients who need them.

Need for real-time data is driving Indian pharma to digitise supply chains

Need for real-time data is driving Indian pharma to digitise supply chains

Oct 04, 2021

If digitising the supply chain has become most critical, the ask is really to put in place an end-to-end solution that can help bring in operational efficiency, improve business forecasting, inventory management apart from better demand and supply planning.

Indian Pharma companies help Ivory Coast gain freedom from diseases

Indian Pharma companies help Ivory Coast gain freedom from diseases

Oct 04, 2021

Talking to Financial Express Online, Ambassador Sailas Thangal said “In November and December, the mission will be organising camps and donation drives across various regions of the country. Indian pharma companies will be part of this drive on November 13 and then another one on December 11, 2021.”

Indian pharma market sees non-COVID drug sales recover

Indian pharma market sees non-COVID drug sales recover

Sep 30, 2021

The past 18 months that forced people into social isolation and to home food and home remedies saw fewer people complaining of cold, cough and gastro-intestinal problems.

Enzene gets DCGI nod for biosimilar drug to treat haematological disorder

Enzene gets DCGI nod for biosimilar drug to treat haematological disorder

Sep 28, 2021

The symptoms of this disorder ranges from mild skin bleeding and bruises to potentially fatal internal bleeding, such as in the gastrointestinal tract and the brain.

Indian Pharma: a strategic sector from ‘Make in India’ to ‘Make and Develop in India’

Indian Pharma: a strategic sector from ‘Make in India’ to ‘Make and Develop in India’

Sep 28, 2021

Poised to grow to USD 120 to 130 billion by 2030, the pharma sector contributes significantly to India’s economic growth— 1.7 percent to the country’s GDP last year as compared to its contribution at one percent, a decade ago.

Biocon Biologics-SILS alliance to help in fighting infectious diseases: Kiran Mazumdar-Shaw

Biocon Biologics-SILS alliance to help in fighting infectious diseases: Kiran Mazumdar-Shaw

Sep 28, 2021

On Thursday, Biocon Biologics, a subsidiary of Biocon, had said it will offer around 15 per cent stake to Serum Institute Life Sciences (SILS), at a post-money valuation of about USD 4.9 billion.

Hetero gets DCGI nod to launch biosimilar version of Tocilizumab

Hetero gets DCGI nod to launch biosimilar version of Tocilizumab

Sep 28, 2021

The Hyderabad-based company said on Monday the drug would be available in the country by the end of September under the brand name Tocira.

DCGI directs bulk drugs manufacturers to submit applications online of already issued valid WCCs

DCGI directs bulk drugs manufacturers to submit applications online of already issued valid WCCs

Sep 28, 2021

The WCC is compulsory for exporting active pharmaceutical ingredients (APIs) to European Union (EU) countries.

Snarled supply chains hurt Indian pharma copying with spurt in Chinese raw material prices

Snarled supply chains hurt Indian pharma copying with spurt in Chinese raw material prices

Sep 28, 2021

Many in the pharma industry are today reminded of the days when the pandemic began unfolding early last year.